DSE:LIBRAINFU

Libra Infusions Limited announcements

229 Dhaka Stock Exchange announcements for Libra Infusions Limited (LIBRAINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (22).

  1. Q2 Financials (Additional Information)

    (Q2 Un-audited): The company has further informed that EPS was Tk. (1.48) for October-December 2020 as against Tk. (1.07) for October-December 2019. The company has informed that EPS has been decreased due to decrease of turnover. NOCFPS has been increased due to minimum payment to supplier, employees and others. Production was hampered due to acute shortage of working capital, as a result Turnover has been decreased.

  2. Q1 Financials (Additional Information)

    (Q1 Un-audited): The company has further informed that EPS has been decreased due to decrease of turnover. NOCFPS has been increased due to minimum payment to supplier, employees and others. Production was hampered due to acute shortage of working capital, as a result Turnover has been decreased.

  3. Q3 Financials

    (Q3 Un-audited): EPS was Tk. (6.44) for July 2020-March 2021 as against Tk. (5.24) for July 2019-March 2020. NOCFPS was Tk. 4.59 for July 2020-March 2021 as against Tk. 7.02 for July 2019-March 2020. NAV per share was Tk. 1,254.00 as on March 31, 2021 and Tk. 1,264.00 as on March 31, 2020.

  4. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 0.69 for July-September 2020 as against Tk. 1.55 for July-September 2019. NOCFPS was Tk. 6.75 for July-September 2020 as against Tk. 3.11 for July-September 2019. NAV per share was Tk. 1,262.00 as on September 30, 2020 and Tk. 1,271.00 as on September 30, 2019.

  5. Q2 Financials

    (Q2 Un-audited): EPS was Tk. (0.75) for July-December 2020 as against Tk. 0.91 for July-December 2019. NOCFPS was Tk. 9.70 for July-December 2020 as against Tk. 2.03 for July-December 2019. NAV per share was Tk. 1,260.00 as on December 31, 2020 and Tk. 1,270.00 as on December 31, 2019.

  6. Q3 Financials (Additional Information)

    (Q3 Un-audited): The company has further informed that EPS was Tk. (5.69) for January-March 2021 as against Tk. (6.10) for January-March 2020. The company has informed that EPS has been decreased due to decrease of turnover. NOCFPS has been increased due to minimum payment to supplier, employees and others. Production was hampered due to acute shortage of working capital, as a result Turnover has been decreased.

  7. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on December 18, 2022 at 3:00 PM, 3:30 PM and 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2020, Second Quarter (Q2) period ended December 31, 2020 and Third Quarter (Q3) period ended March 31, 2021 respectively.

  8. Dividend Disbursement

    The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2020 to the respective shareholders.

  9. Category Change

    The Company will be placed in 'B' category from existing 'A' category with effect from August 22, 2022 as the Company has approved 5% cash dividend for the year ended June 30, 2020.

  10. The auditor of the Libra Infusions Limited has given the \"Qualified Opinion\" paragraph in the Auditor\'s Report for th

    The auditor of the Libra Infusions Limited has given the \"Qualified Opinion\" paragraph in the Auditor\'s Report for the year ended 30 June 2020. Basis for Qualified Opinion: 1. No Deprecation has been charged for the fixed assets in Unit-2 during the year which would be Tk. 37,345,698 approximately. Further, deferred tax for revaluation of building and construction of the unit has also not been recognized. (cont.)

  11. Qualified Opinion

    (Continuation news of LIBRAINFU): 2. Outstanding Loan liability with Al-Arafah Islami Bank Limited as per outstanding liability position statement stands at Tk. 1,082,237,660 but loan liability recognized in balance sheet at Tk. 845,913,379 resulting a shortfall in liability of Tk. 236,324,281. (end)

    The first part of this announcement is missing from the archive.
  12. Resumption after record date

    Trading of the shares of the company will resume on 14.08.2022 after record date.

  13. Suspension for Record date

    Trading of the shares will remain suspended on record date i.e., 11.08.2022.

  14. Spot News

    Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 08.08.2022 to 10.08.2022 and trading of the shares will remain suspended on record date i.e., 11.08.2022.

  15. Dividend Declaration

    The Board of Directors has recommended 5% cash dividend only for General Shareholders other than Sponsors and Directors for the year ended June 30, 2020. Date of AGM: 21.08.2022 (as per Court Order), Time: 11:00 AM, Venue: Digital Platform. Record Date: 11.08.2022. The Company has also reported EPS of Tk. (7.78), NAV per share of Tk. 1,261.00 and NOCFPS of Tk. (0.14) for the year ended June 30, 2020 as against Tk.1.05, Tk. 1,269.00 and Tk. 9.77 respectively for the same period of the previous year.

  16. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (24.07.2022) following its corporate declaration.

  17. Reschedule of Board Meeting under LR 19(1)

    The Company has further informed that, due to unavoidable circumstances, the Board meeting under LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will now be held on July 21, 2022 at 4:00 PM instead of July 14, 2022 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2020.

  18. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 14, 2022 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2020.

  19. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 1.55 for July-September 2019 as against Tk. 2.31 for July-September 2018; NOCFPS was Tk. 3.11 for July-September 2019 as against Tk. 7.58 for July-September 2018. NAV per share was Tk. 1,271.00 as on September 30, 2019 and Tk. 1,523.00 as on June 30, 2019.

  20. Q2 Financials

    (Q2 Un-audited): EPS was Tk. (1.07) for October-December 2019 as against Tk. (9.79) for October-December 2018; EPS was Tk. 0.91 for July-December 2019 as against Tk. (8.03) for July-December 2018. NOCFPS was Tk. 2.03 for July-December 2019 as against Tk. 8.81 for July-December 2018. NAV per share was Tk. 1,270.00 as on December 31, 2019 and Tk. 1,523.00 as on June 30, 2019.

  21. Q3 Financials

    (Q3 Un-audited): EPS was Tk. (6.10) for January-March 2020 as against Tk. (11.38) for January-March 2019; EPS was Tk. (5.24) for July 2019-March 2020 as against Tk. (18.07) for July 2018-March 2019. NOCFPS was Tk. 7.02 for July 2019-March 2020 as against Tk. 2.84 for July 2018-March 2019. NAV per share was Tk. 1,264.00 as on March 31, 2020 and Tk. 1,523.00 as on June 30, 2019.

  22. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that meetings of the Board of Directors will be held on July 07, 2022 at 3:00 PM, 3:30 PM and 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2019; Second Quarter (Q2) period ended December 31, 2019 and Third Quarter (Q3) period ended March 31, 2020.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.